- A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)2017 | Faculty of Medicine in Hradec Králové
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma2015 | Faculty of Medicine in Hradec Králové